Related Experiment Video
Updated: Feb 7, 2026
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
Translational potential of ginsenoside Rb1 in managing progression of osteoarthritis
Yuanfeng Chen1,2, Sien Lin1,2, Yuxin Sun1,2
1Department of Orthopaedics and Traumatology, Li Ka Shing Institute of Health Sciences and Lui Che Woo Institute of Innovative Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Background:
Osteoarthritis (OA) is the most common degenerative joint disorder. Inflammatory cytokine plays an important role in OA progression. Previous studies have demonstrated that ginsenoside Rb1 would prevent inflammation and apoptosis in chondrocytes. However, we have not found any animal study reporting that Rb1 attenuates the severity of OA.
Objective:
In this study, we used a rat anterior cruciate ligament transaction plus medial meniscus resection (ACLT + MMx) model of OA and a cell model, to investigate whether administration of ginsenoside Rb1 may attenuate the progression of arthritis.
Methods:
In this in vivo study, 16-week-old male Sprague-Dawley rats were divided into three groups: Group 1 (sham control group), Group 2 (Rb1-treated group), and Group 3 (OA group). In Groups 2 and 3, OA was induced in the right knee joint with ACLT + MMx in rats. Then Group 2 received continuous infusion of ginsenoside Rb1 via osmotic mini-pumps implanted subcutaneously. At 4 weeks after treatment, the rats were sacrificed. Interleukin-1β (IL-1β) level was evaluated by enzyme-linked immunosorbent assay (ELISA); cartilage damage was assessed via histology (Safranin-O/fast green stain) and immunohistochemistry [matrix metalloproteinase-13 (MMP13) and type X collagen (Col X)]. For cell study, C5.18 (rat chondrocyte cell line) was used in this research. The effect of Rb1 on IL-1β-induced MMP13 or Col X expression level in C5.18 cells was investigated.
Results:
In this in vivo study, characteristics of OA were present in the OA group, in contrast to less severe damage generally observed in the Rb1 treatment group: first, IL-1β level was significantly decreased, and second, cartilage degeneration was attenuated, as indicated by lower histologic damage scores and lower percentages of MMP13 or Col X-positive chondrocytes. In the cell study, the results showed that Rb1 treatment would relieve the MMP13 or Col X expression in C5.18 cells induced by IL-1β.
Conclusion:
In the present study, we demonstrated that Rb1 can attenuate the progression or severity of arthritis by reducing inflammation.
Insights
Ginsenoside Rb1 treatment reduced inflammation and cartilage damage in a rat osteoarthritis model. This study shows Rb1 may be a potential therapeutic agent for osteoarthritis by mitigating inflammatory responses.
Area of Science:
- Pharmacology
- Biochemistry
- Orthopedics
Background:
- Osteoarthritis (OA) is a prevalent degenerative joint disease.
- Inflammatory cytokines are key drivers of OA progression.
- Ginsenoside Rb1 has shown anti-inflammatory and anti-apoptotic effects in chondrocytes.
Purpose of the Study:
- To investigate the therapeutic potential of ginsenoside Rb1 in an animal model of OA.
- To evaluate the effect of Rb1 on arthritis progression and severity.
Main Methods:
- An osteoarthritis model was created in rats using anterior cruciate ligament transaction plus medial meniscus resection (ACLT + MMx).
- Rats received continuous ginsenoside Rb1 infusion or served as controls.
- Cartilage damage, Interleukin-1β (IL-1β) levels, and expression of MMP13 and Col X were assessed.
Main Results:
- Rb1 treatment significantly decreased IL-1β levels in OA rats.
- Histological analysis showed attenuated cartilage degeneration in Rb1-treated rats.
- Rb1 reduced the expression of MMP13 and Col X in both in vivo and in vitro models.
Conclusions:
- Ginsenoside Rb1 demonstrates potential in attenuating osteoarthritis progression.
- Rb1's therapeutic effect is linked to its ability to reduce inflammation.
- Further research into Rb1 as an OA treatment is warranted.
Related Concept Videos
01:31Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
01:31Translation
Translation Produces the Building Blocks of Life
Proteins are...
02:33Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
01:44Termination of Translation
01:44Termination of Translation
02:07Improving Translational Accuracy